BHVN
Price:
$11.515
Market Cap:
$1.22B
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Industry
Biotechnology
IPO Date
2022-09-23
Stock Exchange
NYSE
Ticker
BHVN
According to Biohaven Ltd.’s latest financial reports and current stock price. The company's current ROE is -389.88%. This represents a change of -312.48% compared to the average of 183.49% of the last 4 quarters.
The mean historical ROE of Biohaven Ltd. over the last ten years is 674.79%. The current -389.88% ROE has changed -157.78% with respect to the historical average. Over the past ten years (40 quarters), BHVN's ROE was at its highest in in the December 2019 quarter at 2.01%. The ROE was at its lowest in in the March 2021 quarter at -345.10%.
Average
674.79%
Median
-100.61%
Minimum
-707.16%
Maximum
7.12%
Discovering the peaks and valleys of Biohaven Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 7.12%
Minimum Annual Increase = 0%
Minimum Annual ROE = -707.16%
| Year | ROE | Change |
|---|---|---|
| 2024 | -199.89% | 109.59% |
| 2023 | -95.37% | -9.90% |
| 2022 | -105.85% | -82.82% |
| 2021 | -616.29% | -12.85% |
| 2020 | -707.16% | -109.93% |
| 2019 | 7.12% | Infinity% |
| 2018 | 0% | 0% |
The current ROE of Biohaven Ltd. (BHVN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-133.70%
5-year avg
-344.91%
10-year avg
674.79%
Biohaven Ltd.’s ROE is greater than Intellia Therapeutics, Inc. (-57.24%), greater than Immunome, Inc. (-87.36%), greater than AbCellera Biologics Inc. (-16.95%), greater than Vera Therapeutics, Inc. (-46.70%), greater than Zenas BioPharma, Inc. (-59.19%), greater than Celldex Therapeutics, Inc. (-27.62%), greater than Pharvaris N.V. (-69.10%), less than Xeris Biopharma Holdings, Inc. (113.91%), greater than Sionna Therapeutics, Inc. (-62.72%), greater than Immunocore Holdings plc (-7.42%),
| Company | ROE | Market cap |
|---|---|---|
| -57.24% | $945.70M | |
| -87.36% | $1.79B | |
| -16.95% | $1.09B | |
| -46.70% | $3.18B | |
| -59.19% | $1.70B | |
| -27.62% | $1.83B | |
| -69.10% | $1.57B | |
| 113.91% | $1.19B | |
| -62.72% | $1.91B | |
| -7.42% | $1.85B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biohaven Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biohaven Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biohaven Ltd.'s ROE?
How is the ROE calculated for Biohaven Ltd. (BHVN)?
What is the highest ROE for Biohaven Ltd. (BHVN)?
What is the 3-year average ROE for Biohaven Ltd. (BHVN)?
What is the 5-year average ROE for Biohaven Ltd. (BHVN)?
How does the current ROE for Biohaven Ltd. (BHVN) compare to its historical average?